Your browser doesn't support javascript.
loading
Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial.
Chooi, Yu Chung; Zhang, Qinze Arthur; Magkos, Faidon; Ng, Maisie; Michael, Navin; Wu, Xiaorong; Volchanskaya, Vera Sergeyevna Brok; Lai, Xianning; Wanjaya, Elvy Riani; Elejalde, Untzizu; Goh, Chew Chan; Yap, Clara Poh Lian; Wong, Long Hui; Lim, Kevin Junliang; Velan, S Sendhil; Yaligar, Jadegoud; Muthiah, Mark Dhinesh; Chong, Yap Seng; Loo, Evelyn Xiu Ling; Eriksson, Johan G.
Afiliação
  • Chooi YC; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: chooiyc@sics.a-star.edu.sg.
  • Zhang QA; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore.
  • Magkos F; Department of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.
  • Ng M; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore.
  • Michael N; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore.
  • Wu X; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Volchanskaya VSB; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Lai X; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Wanjaya ER; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Elejalde U; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Goh CC; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Yap CPL; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Wong LH; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore. Electronic address: kat.wonglonghui@sg.wilmar-intl.com.
  • Lim KJ; WIL@NUS Corporate Laboratory, National University of Singapore (NUS), Center for Translational Medicine, Singapore.
  • Velan SS; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore.
  • Yaligar J; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore.
  • Muthiah MD; Department of Gastroenterology and Hepatology, National University Health System, Singapore; National University Centre for Organ Transplantation, Singapore.
  • Chong YS; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore; Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore.
  • Loo EXL; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore; Department of Paediatrics and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore.
  • Eriksson JG; Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), Singapore; Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore; Department of General Practice and Primary Health Care, U
Am J Clin Nutr ; 119(3): 788-799, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38035997
ABSTRACT

BACKGROUND:

Weight loss is the most effective treatment for nonalcoholic fatty liver disease (NAFLD). There is evidence that the Mediterranean diets rich in unsaturated fatty acids and fiber have beneficial effects on weight homeostasis and metabolic risk factors in individuals with NAFLD. Studies have also shown that higher circulating concentrations of pentadecanoic acid (C150) are associated with a lower risk for NAFLD.

OBJECTIVES:

To examine the effects of a Mediterranean-like, culturally contextualized Asian diet rich in fiber and unsaturated fatty acids, with or without C150 supplementation, in Chinese females with NAFLD.

METHODS:

In a double-blinded, parallel-design, randomized controlled trial, 88 Chinese females with NAFLD were randomly assigned to 1 of the 3 groups for 12 wk diet with C150 supplementation (n = 31), diet without C150 supplementation (n = 28), or control (habitual diet and no C150 supplementation, n = 29). At baseline and after the intervention, body fat percentage, intrahepatic lipid content, muscle and abdominal fat, liver enzymes, cardiometabolic risk factors, and gut microbiome were assessed.

RESULTS:

In the intention-to-treat analysis, weight reductions of 4.0 ± 0.5 kg (5.3%), 3.4 ± 0.5 kg (4.5%), and 1.5 ± 0.5 kg (2.1%) were achieved in the diet-with-C150, diet without-C150, and the control groups, respectively. The proton density fat fraction (PDFF) of the liver decreased by 33%, 30%, and 10%, respectively. Both diet groups achieved significantly greater reductions in body weight, liver PDFF, total cholesterol, gamma-glutamyl transferase, and triglyceride concentrations compared with the control group. C150 supplementation reduced LDL-cholesterol further, and increased the abundance of Bifidobacterium adolescentis. Fat mass, visceral adipose tissue, subcutaneous abdominal adipose tissue (deep and superficial), insulin, glycated hemoglobin, and blood pressure decreased significantly in all groups, in parallel with weight loss.

CONCLUSION:

Mild weight loss induced by a Mediterranean-like diet adapted for Asians has multiple beneficial health effects in females with NAFLD. C150 supplementation lowers LDL-cholesterol and may cause beneficial shifts in the gut microbiome. TRIAL REGISTRATION NUMBER This trial was registered at the clinicaltrials.gov as NCT05259475.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dieta Mediterrânea / Ácidos Graxos / Hepatopatia Gordurosa não Alcoólica Limite: Female / Humans Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dieta Mediterrânea / Ácidos Graxos / Hepatopatia Gordurosa não Alcoólica Limite: Female / Humans Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2024 Tipo de documento: Article